TY - JOUR
T1 - Group-constrained sparse fMRI connectivity modeling for mild cognitive impairment identification
AU - Wee, Chong Yaw
AU - Yap, Pew Thian
AU - Zhang, Daoqiang
AU - Wang, Lihong
AU - Shen, Dinggang
N1 - Funding Information:
This work was supported in part by National Institute of Health (NIH) grants EB006733, EB008374, AG041721, EB009634, MH088520, K23-AG028982, as well as a National Alliance for Research in Schizophrenia and Depression Young Investigator Award (L.W.). Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health ( http://www.fnih.org ). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation.
PY - 2014/3
Y1 - 2014/3
N2 - Emergence of advanced network analysis techniques utilizing resting-state functional magnetic resonance imaging (R-fMRI) has enabled a more comprehensive understanding of neurological disorders at a whole-brain level. However, inferring brain connectivity from R-fMRI is a challenging task, particularly when the ultimate goal is to achieve good control-patient classification performance, owing to perplexing noise effects, curse of dimensionality, and inter-subject variability. Incorporating sparsity into connectivity modeling may be a possible solution to partially remedy this problem since most biological networks are intrinsically sparse. Nevertheless, sparsity constraint, when applied at an individual level, will inevitably cause inter-subject variability and hence degrade classification performance. To this end, we formulate the R-fMRI time series of each region of interest (ROI) as a linear representation of time series of other ROIs to infer sparse connectivity networks that are topologically identical across individuals. This formulation allows simultaneous selection of a common set of ROIs across subjects so that their linear combination is best in estimating the time series of the considered ROI. Specifically, l1-norm is imposed on each subject to filter out spurious or insignificant connections to produce sparse networks. A group-constraint is hence imposed via multi-task learning using a l 2-norm to encourage consistent non-zero connections across subjects. This group-constraint is crucial since the network topology is identical for all subjects while still preserving individual information via different connectivity values. We validated the proposed modeling in mild cognitive impairment identification and promising results achieved demonstrate its superiority in disease characterization, particularly greater sensitivity to early stage brain pathologies. The inferred group-constrained sparse network is found to be biologically plausible and is highly associated with the disease-associated anatomical anomalies. Furthermore, our proposed approach achieved similar classification performance when finer atlas was used to parcellate the brain space.
AB - Emergence of advanced network analysis techniques utilizing resting-state functional magnetic resonance imaging (R-fMRI) has enabled a more comprehensive understanding of neurological disorders at a whole-brain level. However, inferring brain connectivity from R-fMRI is a challenging task, particularly when the ultimate goal is to achieve good control-patient classification performance, owing to perplexing noise effects, curse of dimensionality, and inter-subject variability. Incorporating sparsity into connectivity modeling may be a possible solution to partially remedy this problem since most biological networks are intrinsically sparse. Nevertheless, sparsity constraint, when applied at an individual level, will inevitably cause inter-subject variability and hence degrade classification performance. To this end, we formulate the R-fMRI time series of each region of interest (ROI) as a linear representation of time series of other ROIs to infer sparse connectivity networks that are topologically identical across individuals. This formulation allows simultaneous selection of a common set of ROIs across subjects so that their linear combination is best in estimating the time series of the considered ROI. Specifically, l1-norm is imposed on each subject to filter out spurious or insignificant connections to produce sparse networks. A group-constraint is hence imposed via multi-task learning using a l 2-norm to encourage consistent non-zero connections across subjects. This group-constraint is crucial since the network topology is identical for all subjects while still preserving individual information via different connectivity values. We validated the proposed modeling in mild cognitive impairment identification and promising results achieved demonstrate its superiority in disease characterization, particularly greater sensitivity to early stage brain pathologies. The inferred group-constrained sparse network is found to be biologically plausible and is highly associated with the disease-associated anatomical anomalies. Furthermore, our proposed approach achieved similar classification performance when finer atlas was used to parcellate the brain space.
KW - Group-constrained sparse modeling
KW - Inter-subject variability
KW - Mild cognitive impairment (MCI)
KW - Multi-task learning
KW - Resting-state fMRI
KW - Sparse linear regression
UR - http://www.scopus.com/inward/record.url?scp=84896048486&partnerID=8YFLogxK
U2 - 10.1007/s00429-013-0524-8
DO - 10.1007/s00429-013-0524-8
M3 - Article
C2 - 23468090
AN - SCOPUS:84896048486
SN - 1863-2653
VL - 219
SP - 641
EP - 656
JO - Brain Structure and Function
JF - Brain Structure and Function
IS - 2
ER -